Insider and Congress filings

Albemarle Corporation (ALB)

Specialty Chemicals, listed on NYSE.

S&P 500326 insider transactions85 Congress tradeslast filed Nov 10, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

EarningsQ3 FY2026 · reported Nov 4, 2026

Albemarle beat by 2.0% on adjusted EPS.

$2.58 a share against a $2.53 consensus. Revenue $1.55B against $1.52B, a beat of 2.3%.

EPS

Reported$2.58
Consensus$2.53

Revenue

Reported$1.55B
Consensus$1.52B

Beat 5Miss 1

Next report Feb 10, 2027. Consensus $1.52 a share.

Every quarter

Money managers13F filings for Jun 30, 2026

948

institutions reported Albemarle shares in 13F filings for Jun 30, 2026. Capital World Investors held the largest stake, $1.3B.

The largest holders

Capital World Investors$1.3B
BlackRock, Inc.$1.3B
Vanguard Capital Management LLC$1.0B
Every holder

Insider tradesForm 4 · 4 open-market filings shown

Four open-market sales.

Feb 13, 2026May 15, 2026

Sales

A median 2 business days from trade to filing. Form 4 is due within two.

Every filing

CongressSTOCK Act disclosures to the House and Senate

20 Congress disclosures shown, from 4 members.

29dMedian delayof the 45 day limit
10 buys · 10 sellsPurchases and sales in the disclosures shown

2 members of Congress report a position in ALB, by our estimate. Who holds it

Every Congress trade in ALBEvery disclosure
Companyfrom the company's filings and listing, as of Nov 12, 2026

About Albemarle Corporation

Exchange
NYSE
Sector
Basic Materials
Industry
Chemicals - Specialty
Chief executive
Jerry Kent Jr.
Employees
7,800
Listed since
Feb 22, 1994
Market value
$11.3B
Price to earnings (12 mo)
22.0
Net income per share, as reported (12 mo)
$5.78
Dividend yield
1.69%

www.albemarle.com

Earnings6 reported quarters · next on Feb 10, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Nov 4, 2026$2.58$2.53$1.6B$1.5BEPS beatRevenue beat
Q2 FY2026reported Aug 5, 2026$3.75$3.20$1.7B$1.6BEPS beatRevenue beat
Q1 FY2026reported May 6, 2026$2.95$1.19$1.4B$1.3BEPS beatRevenue beat
Q4 FY2025reported Feb 11, 2026-$0.53-$0.42$1.4B$1.3BEPS missRevenue beat
Q3 FY2025reported Nov 5, 2025-$0.19-$0.86$1.3B$1.3BEPS beatRevenue beat
Q2 FY2025reported Jul 30, 2025$0.11-$0.83$1.3B$1.3BEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

No earnings call briefs on ALB yet. Briefs from every company we cover.

Analysts

Analyst ratings and price targets

Past year Each firm's latest target, newest first

Each firm's latest price target on ALB, newest first
FirmRatingTargetActionDate
ScotiabankSector Outperform$165Cut from $190
Truist SecuritiesBuy$185Cut from $225
RBC CapitalOutperform$129Target set
BarclaysEqual Weight$109Initiated
ArgusBuy$135Cut from $230
BMO CapitalOutperformrated Aug 7, 2026$175Target set
UBSBuy$150Cut from $175
Morgan StanleyEqual Weight$161Cut from $189
Deutsche BankBuy$250Target set
BerenbergNot stated$153Target set
Evercore ISIIn Line$180Target set
Wells FargoNot stated$165Cut from $174
OppenheimerOutperform$207Target set
HSBCBuy$200Target set
JefferiesBuy$167Target set

Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.

6 other firms rated ALB in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 13, 2026.

Proxy statementas filed for fiscal 2025 · proxy filed Mar 24, 2026

Executive pay

J. Kent Masters, Jr.’s pay as CEO came to $15.5M for fiscal 2025.
ExecutiveSalaryStock awardsOtherTotal
J. Kent Masters, Jr.Chairman and Chief Executive Officer$1.4M$7.9M$6.2M$15.5M
Eric W. NorrisExecutive Vice President, Chief Commercial Officer$654K$2.0M$1.6M$4.2M
Neal R. SheoreyExecutive Vice President and Chief Financial Officer$622K$2.0M$1.5M$4.1M
Melissa H. AndersonExecutive Vice President, Chief Business Transformation Officer$572K$1.4M$1.3M$3.2M
Mark R. MummertExecutive Vice President, Chief Operations Officer$511Kn/a$954K$2.5M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

13F filings13F positions as of Jun 30, 2026

Institutional holders

HolderValueSharesShares vs prior qtr% of shares out
Capital World Investors$1.3B9,901,852+0.7%8.39%
BlackRock, Inc.$1.3B9,501,587+8.8%8.05%
Vanguard Capital Management LLC$1.0B7,703,012+0.5%6.53%
Vanguard Portfolio Management LLC$869.2M6,436,930+1.9%5.46%
State Street Corp$744.8M5,500,062+5.3%4.67%
Barclays PLC$445.1M3,296,551+166.8%2.79%
Geode Capital Management, LLC$421.9M3,129,997-8.9%2.65%
Morgan Stanley$391.0M2,895,892+28.8%2.46%
FMR LLC$362.7M2,685,901+1054.8%2.28%
Primecap Management Co$358.1M2,652,009-0.5%2.25%
Bank of America Corp$343.4M2,543,325-14.5%2.16%
VanEck Associates Corp$293.7M2,174,797+7.9%1.84%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Form 44 filings shown · newest filing first

Open-market insider trades

InsiderActionSharesPriceValueTrade dateDelay
(business days)
J. Kent MastersChairman & CEOSold · 3 lines16,393$183.72$3.0MMay 15, 2026filed May 19, 20262d
J. Kent MastersChairman & CEOSold · 3 lines11,783$170.81$2.0MMar 10, 2026filed Mar 12, 20262d
Eric NorrisChief Commercial OfficerSold5,692$165.45$942KFeb 20, 2026filed Feb 23, 20261d
Melissa H. AndersonChief Bus..transformation Off.Sold8,454$163.71$1.4MFeb 13, 2026filed Feb 18, 20262d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
Neal Ravi SheoreyChief Financial OfficerTax withholding849Nov 6, 2026
Alejandro Daniel WolffDirectorStock award45Oct 1, 2026
Autumn M. GagarinasChief People OfficerStock award5,217Sep 14, 2026
Mark Richard MummertChief Operations OfficerStock award6,086Sep 14, 2026
Eric NorrisChief Commercial OfficerStock award10,867Sep 14, 2026
Max HoodChief Accounting OfficerStock award1,476Sep 1, 2026
Bartolomeo Eduardo DesallesDirectorStock award1,375Jul 21, 2026
Diarmuid B. OConnellDirectorStock award1,286Jul 1, 2026
Holly Van DeursenDirectorStock award1,250Jul 1, 2026
Gerald A. SteinerDirectorStock award1,286Jul 1, 2026
Mark R. WidmarDirectorStock award1,250Jul 1, 2026
Alejandro Daniel WolffDirectorStock award1,283Jul 1, 2026
Laurie BrlasDirectorStock award1,286Jul 1, 2026
Ralf Hans CramerDirectorTax withholding942Jul 1, 2026
Ralf Hans CramerDirectorStock award1,286Jul 1, 2026
Michelle T. CollinsDirectorStock award1,252Jul 1, 2026
Glenda J. MinorDirectorStock award1,250Jul 1, 2026
Alejandro Daniel WolffDirectorStock award25Apr 1, 2026
J. Kent MastersChairman & CEOGift30,716Mar 12, 2026
Alejandro Daniel WolffDirectorStock award25Oct 3, 2023

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

STOCK Act20 disclosures of 85 on record · median 29d of the 45 allowed

Congress trades in ALB

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000-13.6% since the tradeEstimated entry price $109.73, close on Fri Sep 25Current price $94.85, close on Thu Nov 12Sep 25, 2026Oct 7, 202612d
Ro KhannaStockSale$1,001 - $15,000-19.8% since the saleEstimated exit price $118.20, close on Mon Jul 20Current price $94.85, close on Thu Nov 12Jul 20, 2026Aug 7, 202618d
John BoozmanJointStockPurchase$1,001 - $15,000-47.4% since the tradeEstimated entry price $180.38, close on Fri May 15Current price $94.85, close on Thu Nov 12May 15, 2026Jun 16, 202632d
Ro KhannaStockPurchase$1,001 - $15,000-39.4% since the tradeEstimated entry price $156.48, close on Thu Feb 5Current price $94.85, close on Thu Nov 12Feb 5, 2026Mar 9, 202632d
Jefferson ShreveStockSale$15,001 - $50,000+54.1% since the saleEstimated exit price $61.57, close on Mon May 12, 2025Current price $94.85, close on Thu Nov 12May 12, 2025Jun 22, 202541d
Ro KhannaStockPurchase$1,001 - $15,000+70.5% since the tradeEstimated entry price $55.64, close on Wed Apr 23, 2025Current price $94.85, close on Thu Nov 12Apr 23, 2025May 12, 202519d
Jefferson ShreveStockPurchase$15,001 - $50,000+63.3% since the tradeEstimated entry price $58.10, close on Mon Apr 7, 2025Current price $94.85, close on Thu Nov 12Apr 7, 2025May 8, 202531d
Ro KhannaStockSale$1,001 - $15,000+24.0% since the saleEstimated exit price $76.48, close on Thu Mar 6, 2025Current price $94.85, close on Thu Nov 12Mar 6, 2025Apr 10, 202535d
Ro KhannaStockSale$1,001 - $15,000+30.3% since the saleEstimated exit price $72.81, close on Wed Mar 12, 2025Current price $94.85, close on Thu Nov 12Mar 12, 2025Apr 10, 202529d
Ro KhannaStockSale$15,001 - $50,000+22.3% since the saleEstimated exit price $77.56, close on Fri Mar 21, 2025Current price $94.85, close on Thu Nov 12Mar 21, 2025Apr 10, 202520d
Julie JohnsonJointStockSale$1,001 - $15,000+23.8% since the saleEstimated exit price $76.60, close on Wed Feb 12, 2025Current price $94.85, close on Thu Nov 12Feb 12, 2025Mar 12, 202528d
Jefferson ShreveStockSale$15,001 - $50,000+17.1% since the saleEstimated exit price $81.03, close on Mon Feb 24, 2025Current price $94.85, close on Thu Nov 12Feb 24, 2025Mar 9, 202513d
Ro KhannaStockSale$1,001 - $15,000+21.0% since the saleEstimated exit price $78.42, close on Tue Feb 25, 2025Current price $94.85, close on Thu Nov 12Feb 25, 2025Mar 6, 20259d
Ro KhannaStockPurchase$1,001 - $15,000+9.0% since the tradeEstimated entry price $86.99, close on Fri Aug 2, 2024Current price $94.85, close on Thu Nov 12Aug 2, 2024Sep 6, 202435d
Ro KhannaStockSale$1,001 - $15,000+9.0% since the saleEstimated exit price $86.99, close on Fri Aug 2, 2024Current price $94.85, close on Thu Nov 12Aug 2, 2024Sep 6, 202435d
Ro KhannaStockPurchase$1,001 - $15,000+13.6% since the tradeEstimated entry price $83.52, close on Mon Aug 5, 2024Current price $94.85, close on Thu Nov 12Aug 5, 2024Sep 6, 202432d
Ro KhannaStockSale$1,001 - $15,000-2.3% since the saleEstimated exit price $97.06, close on Tue Jul 2, 2024Current price $94.85, close on Thu Nov 12Jul 2, 2024Aug 7, 202436d
Ro KhannaStockPurchase$15,001 - $50,000+1.1% since the tradeEstimated entry price $93.79, close on Thu Jun 20, 2024Current price $94.85, close on Thu Nov 12Jun 20, 2024Jul 8, 202418d
Ro KhannaStockPurchase$15,001 - $50,000-1.6% since the tradeEstimated entry price $96.40, close on Mon Jun 24, 2024Current price $94.85, close on Thu Nov 12Jun 24, 2024Jul 8, 202414d
Ro KhannaStockPurchase$1,001 - $15,000-25.8% since the tradeEstimated entry price $127.76, close on Tue May 28, 2024Current price $94.85, close on Thu Nov 12May 28, 2024Jun 5, 20248d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

Every Congress trade in ALB filterable by party, chamber, type and account.

STOCK Act2 members · estimate, as of Nov 12, 2026

Members of Congress reporting a position

2 members report a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
Deborah K. RossDemocrat · House$1,001 - $15,0000.4%
John BoozmanRepublican · Senate$1,001 - $15,0000.2%

The largest estimated position is in the $1,001 - $15,000 band. Estimate, as of Nov 12, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 13, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on ALB show and how current they are.

Are insiders buying or selling ALB?

Across the 4 most recent open-market filings shown here, 0 were purchases and 4 were sales.

Which members of Congress have traded ALB?

Ro Khanna, John Boozman, Jefferson Shreve and Julie Johnson disclosed ALB transactions in the filings shown here.

Which members of Congress hold ALB?

2 members of Congress report a position in ALB in the estimate we hold as of Nov 12, 2026. The estimated positions belong to Deborah K. Ross and John Boozman. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is ALB in the S&P 500 or the Nasdaq 100?

Albemarle Corporation is a current member of the S&P 500, per the membership list we hold as of Nov 13, 2026. Current members of either index get a page here whatever their filing history.

How quickly are ALB trades disclosed?

Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track